Telehealth in rheumatology: From ‘boutique industry’ to ‘unavoidable reality’
It is quite possible that, when all is said and done, the most lasting impact of COVID-19 on rheumatology will be the overwhelming uptake of telemedicine in daily clinical practice.The question, then, is what telerheumatology will look like when the pandemic subsides.“Before COVID, telemedicine was a boutique industry in rheumatology,” Daniel Albert, MD, vice chair of faculty and academic affairs in the department of medicine at Dartmouth-Hitchcock Medical Center, in Lebanon, New Hampshire, told Healio Rheumatology. “That changed 180 degrees with the pandemic.”AlthoughRead More
